Industry, research push for clarity in clinical trial eligibility guidances
Regulatory NewsMary Ellen Schneider
Biologics/ biosimilars/ vaccinesClinical TrialsGuidancePharmaceuticalsUnited StatesRegulatory NewsMary Ellen SchneiderBiologics/ biosimilars/ vaccinesClinical TrialsGuidancePharmaceuticalsUnited States